This episode dives into how innovative technologies are enabling point-of-care clinical decision support, ensuring patients gain seamless access to potentially life-saving genetic information throughout their healthcare journey.

Rome and ⁠Feyi Ayodele, CEO of Cancer IQ ⁠and one of Modern Healthcare's 2024 Innovator's List, explore strategies to break down traditional barriers to patient access that empower primary care physicians (PCPs) and specialists to integrate genetic and genomic insights directly into routine appointments. Discover how digital solutions are transforming patient selection for hereditary cancer testing – including crucial breast cancer risk assessments – and streamlining access to precision medicine. We'll also uncover how these advancements ...